Risk factors associated with hypertension awareness, treatment, and control in a multi-ethnic Asian population

Journal of Hypertension

Volumn 27, Issue 1, 2009, Pages 190-197

  Wu, Yi ^a   Tai, E Shyong ^b   Heng, Derrick ^c   Tan, Chee Eng ^d   Low, Lip Ping ^e   Lee, Jeannette ^f  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c MINISTRY OF HEALTH   (Singapore)

^d GLENEAGLES HOSPITAL   (Singapore)

^e MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Asian; Awareness; Control; Hypertension; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGE DISTRIBUTION; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ASIAN; AWARENESS; BLOOD EXAMINATION; CARDIOVASCULAR RISK; DEMOGRAPHY; DISEASE CONTROL; EDUCATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; SOCIAL STATUS; WORK; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DRUG EFFECT; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; AWARENESS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RISK FACTORS;

EID: 58849107821     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328317c8c3     Document Type: Article

References (43)

1. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290:898-904.
2. World Health Organization. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) 2003; 16:230.
3. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ. Selected major risk factors and global and regional burden of disease. Lancet 2002;360:1347-1360.
4. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: ?ndings from the Global Burden of Disease study. PLoS Med 2004; 1:e27.
5. Kearney PM,Whelton M, Reynolds K, Muntner P,Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.
6. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. Ann Pharmacother 2007; 41:1770-1781.
7. Fahey T, Schroeder K, Ebrahim S. Educational and organizational interventions used to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract 2005; 55:875-882.
8. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362:1527-1535.
9. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356:1955-1964.
10. Quan A, Kerlikowske K, Gueyf?er F, Boissel JP. Ef?cacy of treatinghypertension in women. J Gen Intern Med 1999; 14:718-729.
11. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2: Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990; 335:827-838.
12. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22:11-19.
13. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR,Giampaoli S, JoffresMR, et al. Hypertension treatment and control in ?ve European countries, Canada, and the United States. Hypertension 2004; 43:10-17.
14. Agyemang C, Bruijnzeels MA, Owusu-Dabo E. Factors associated with hypertension awareness, treatment, and control in Ghana, West Africa.J Hum Hypertens 2006; 20:67-71.
15. Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, He J. Factors associated with hypertension awareness, treatment, and control in a representative sample of the Chinese population. Hypertension 2004; 43:578-585.
16. Agyemang C, van Valkengoed I, Koopmans R, Stronks K. Factors associated with hypertension awareness, treatment and control among ethnic groups in Amsterdam, the Netherlands: the SUNSET study. J Hum Hypertens 2006; 20:874-881.
17. He J, Muntner P, Chen J, Roccella EJ, Streiffer RH, Whelton PK. Factors associated with hypertension control in the general population of the United States. Arch Intern Med 2002; 162:1051-1058.
18. Wyatt SB, Akylbekova EL, Wofford MR, Coady SA, Walker ER, Andrew ME, et al. Prevalence, awareness, treatment, and control of hypertension in the Jackson heart study. Hypertension 2008; 51:650-656.
19. Perez-Fernandez R, Marino AF, Cadarso-Suarez C, Botana MA, Tome MA, Solache I, et al. Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens 2007; 21:366-373.
20. Ministry of Health, Singapore. National Health Survey; 2004. Available at http //www.moh.gov.sg/mohcorp/pressreleases.aspx?id=1440. Accessed 22 May 2008.
21. Hughes K, Yeo PP, Lun KC, Thai AC, Sothy SP, Wang KW, et al. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. II: Differences in risk factor levels. J Epidemiol Commun Health 1990; 44:29-35.
22. Tan CE, Emmanuel SC, Tan BY, Jacob E. Prevalence of diabetes and ethnic differences in cardiovascular risk factors. The 1992 Singapore National Health Survey. Diabetes Care 1999; 22:241-247.
23. Hughes K, Aw TC, Kuperan P, Choo M. Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Commun Health 1997; 51:394-399.
24. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 2001; 79:908-915.
25. Singapore Department of Statistics. Key household income trends; 2007. Available at http://www.singstat.gov.sg/pubn/papers/people/op-s14.pdf. Accessed 22 May 2008.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
27. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
28. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-163.
29. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 2007; 49:69-75.
30. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004; 33:1345-1352.
31. Ministry of Health, Singapore. Clinical practice guidelines: health Screening; 2003. Available at http://www.moh.gov.sg/mohcorp/uploadedFiles/ Publications/Guidelines/Clinical-Practice-Guidelines/Health%20Screening.pdf. Accessed 22 May 2008.
32. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18:139-185.
33. Screening for high blood pressure: U.S. Preventive Services Task Force reaf?rmation recommendation statement. Ann Intern Med 2007;147:783-786.
34. Australia Heart Foundation. Hypertension Management Guide for Doctors; 2004. Available at http://www.heartfoundation.org.au/document/NHF/ hypertension-management-guide-2004.pdf. Accessed 22 May 2008.
35. Franklin SS. Systolic blood pressure: it's time to take control. Am J Hypertens 2004; 17 (Suppl 1):S49-S54.
36. 2003 European Society of Hypertension-European Society of Cardiologyguidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
37. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17:151-83.
38. Gulliford MC. Low rates of detection and treatment of hypertension among current cigarette smokers. J Hum Hypertens 2001; 15:771-773.
39. Holzgreve H. Combination versus monotherapy as initial treatment in hypertension. Herz 2003; 28:725-732.
40. Ruzicka M, Leenen FH. Monotherapy versus combination therapy as ?rst line treatment of uncomplicated arterial hypertension. Drugs 2001; 61:943-954.
41. Giunti S, Cooper M. Does the metabolic syndrome make blood pressure control more dif?cult in diabetes? J Hypertens 2005; 23:2155-2156.
42. Nesbitt SD. Antihypertensive combination therapy: optimizing blood pressure control and cardiovascular risk reduction. J Clin Hypertens (Greenwich) 2007; 9:26-32.
43. Ministry of Health, Singapore. Clinical practice guidelines: hypertension; 2005. Available at http://www.moh.gov.sg/mohcorp/ uploadedFiles/Publications/Guidelines/Clinical-Practice-Guidelines/HPT-Booklet. pdf. Accessed 22 May 2008.